Primary Site >> Stomach Cancer
Gene >> DSPP
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man. PMID: 2831906 |
Ref: Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. PMID: 22104727 |
Ref: ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines. PMID: 24699918 Ref: miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2. PMID: 24875127 |
Ref: siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells. PMID: 25824776 |
Ref: MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C. PMID: 26573417 Ref: MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells. PMID: 27876712 |
Ref: Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells. PMID: 28578256 Ref: Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells. PMID: 28810651 |
Ref: Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a. PMID: 30372881 |